Produkty 34635-42-2

CAS 34635-42-2 występuje w naszej ofercie pod nazwami: 3,17-Di-O-acetyl Androsta-5,14,16-triene-3b,17-diol, 3,17-Di-O-acetyl Androsta-5,14,16-triene-3Beta,17-diol. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 100mg, 25mg, 50mg, 250mg, 500mg.

3,17-Di-O-acetyl Androsta-5,14,16-triene-3b,17-diol
TRC, Biosynth
  • opakowanie: 100mg, 50mg, 25mg, 250mg
  • Warianty: 6
Zobacz produkt
3,17-Di-O-acetyl Androsta-5,14,16-triene-3Beta,17-diol
TRC
  • opakowanie: 25mg, 50mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3R,8R,9S,10R,13S)-17-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12-octahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CAS 34635-42-2) to związek chemiczny o wzorze sumarycznym C23H30O4 i masie molowej 370.5 g/mol. Nazwa systematyczna IUPAC: [(3R,8R,9S,10R,13S)-17-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12-octahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate. InChIKey: URRPYWDJVVVTSE-WBZBWJJNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H30O4
Masa molowa370.5 g/mol
Nazwa IUPAC[(3R,8R,9S,10R,13S)-17-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12-octahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
InChIKeyURRPYWDJVVVTSE-WBZBWJJNSA-N
SMILESCC(=O)O[C@@H]1CC[C@@]2([C@H]3CC[C@]4(C(=CC=C4OC(=O)C)[C@@H]3CC=C2C1)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 3,17-Di-O-acetyl Androsta-5,14,16-triene-3beta,17-diol, 3,17-Di-O-acetyl Androsta-5,14,16-triene-3b,17-diol, (3alpha)-Androsta-5,14,16-triene-3,17-diyl diacetate, Androsta-5,14,16-triene-3beta,17-diol, Diacetate;, 3alpha-Androsta-5,14,16-triene-3,17-diyl diacetate
Izomery (ten sam wzór sumaryczny)
[2-oxo-3-(2,4,6-trimethylphenyl)-1-oxaspiro[4.4]non-3-en-4-yl] 3,3-dimethylbutanoate C23H30O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-13-methyl-16-methylidene-3-oxo-2,6,7,8,9,10,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6-oxo-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-17-yl] pentanoate C23H30O4
[(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(3S,8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-7-oxo-1,2,3,4,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-yl] acetate C23H30O4
[(8R,9S,10R,13S,14S,15S,17R)-13-ethyl-17-ethynyl-17-hydroxy-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-15-yl] acetate C23H30O4
(1'R,5'S,6'S,9'S,10'S,13'R)-5'-methyl-6'-prop-1-ynylspiro[1,3-dioxolane-2,15'-18-oxapentacyclo[11.4.1.01,13.02,10.05,9]octadec-2-ene]-6'-ol C23H30O4